Be part of the knowledge.™

Neurology and Neurosurgery

2550

LikeLikedUnlike

Episodes 181-195 of 762

Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiers
Advancing Schizophrenia Care: Challenges and Promising New Therapies
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Andrew J. Cutler, MD
  Peer
The Role of Neuromodulators in Treating IBS
GI Insights
The Role of Neuromodulators in Treating IBS
- Peter Buch, MD, FACG, AGAF, FACP
  Peer
- Douglas Drossman, MD
  Peer
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiers
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
- Clifford Jack Jr., MD
  Peer
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
- Clifford Jack Jr., MD
  Peer
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
- Ashley Baker, MSN, PMHNP
  Peer
- Suzanne E. Schindler, MD, PhD
  Peer
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
- Ashley Baker, MSN, PMHNP
  Peer
- Vishnu Pandurangadu, MD/MBA, FACEP
  Peer
- Pritikanta Paul, MD
  Peer
advertisement
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiers
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiers
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
NeuroFrontiers
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
- John A. Morren, MD, FAAN, FAANEM
  Peer
Bridging the Gap to Improved Schizophrenia Treatment Options
NeuroFrontiers
Bridging the Gap to Improved Schizophrenia Treatment Options
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
NeuroFrontiers
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
- Kelly G. Gwathmey, MD
  Peer
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
NeuroFrontiers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
advertisement
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
NeuroFrontiers
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
- Brian P. McDonough, MD, FAAFP
  Peer
- John R. Corboy, MD
  Peer
Navigating Treatment Choices for DMD: Key Factors to Consider
NeuroFrontiers
Navigating Treatment Choices for DMD: Key Factors to Consider
- Nancy Kuntz, MD
  Peer
ATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
NeuroFrontiers
ATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
- Morie Gertz, MD, MACP
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended